Clinical research to confirm the safety of bone regenerationpromoting materials

Phase 1

• Conditions: Socket preservation

• Registration Number: JPRN-jRCTs032200108
• Lead Sponsor: Tobita Morikuni

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-07
• Study Completion: 2022-10-04
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

Patients who perform tooth extraction on the premise of the dental implant treatment

Exclusion Criteria

-Active generalized periodontal disease; evident periapical radiolucencies or abscesses
-autoimmune disorders; taking or having a history of bisphosphonate medications or Denosumab (history of MRONJ (medication-related osteonecrosis of the jaw)/BRONJ (bisphosphonate-related osteonecrosis of the jaw))
-Current taking methotrexate(MTX) or steroids.
-Congenital or metabolic bone disorders; or uncontrolled diabetes.
-Current or former smoker or user of chewing tobacco or nicotine-containing products
-Females who are pregnant, breastfeeding, or are planning to conceive during their enrollment in the clinical investigation.
-History of any severe allergic or anaphylactic reactions to collagen or gelatin, or current sensitivity to collagen or gelatin.
-Have a history of complicate malignant tumor.

Study & Design

• Study Type: Interventional
• Study Design: Not specified